#Advocacy

Brain cancer patient begins treatment with experimental vaccine.

Inspiration from the U.S. Conference on AIDS, for the hearts and minds of advocates everywhere

What would the world be like if we didn’t have hepatitis B and C advocates? I shudder to think of it.

Chris Taylor bids farewell to 12 years of hepatitis advocacy with the National Alliance of State and Territorial AIDS Directors (NASTAD).

It remains crystal clear that people and communities who are at risk need to speak up as often as possible.

Chris Taylor reflects on his years of service to public health and the viral hepatitis community.

World Hepatitis Day 2018 has come and gone, but the need for it has not. Viral hepatitis is still here, taking livers and lives.

We will never end the HIV and hepatitis epidemics by preventing people with preexisting conditions from accessing care.

The group focuses on treatment, research, policy and education around HIV and hepatitis C.

On a flight from an advocacy conference, Rick Nash ran into some unexpected turbulence from stigma and ignorance on a plane.

Diagnosed with hepatitis C and HIV, Gloria Searson became a powerful advocate for many.

Longtime hepatitis C activist and advocate, Orlando Chavez died from a massive brain hemorrhage on June 3, 2018 in Oakland, CA.

60 groups sign a letter to state insurance commissioners and attorneys general asking them to reverse the policy.

Here’s how FOSTA-SESTA will endanger sex workers and increase HIV risk.

Controversial legislation would have allowed patients to try experimental therapies without FDA oversight.

Awareness and funding continue to be major challenges when it comes to viral hepatitis advocacy.